Determination of oxidation phenotype by measurement of propafenone urinary metabolic ratios.
Lledó
P
P
Department of Clinical Pharmacology, St. Bartholomew's Hospital, London, UK.
Johnston
A
A
Walker
S
S
Pearson
R M
RM
Turner
P
P
D000328:Adult; D002849:Chromatography, Gas; D003647:Debrisoquin / Q000031:analogs & derivatives / Q000378:metabolism / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction; D010641:Phenotype; D011405:Propafenone / Q000652:urine*
C012359:4-hydroxydebrisoquin; D011405:Propafenone; D003647:Debrisoquin